Trial | NCT01800708  Report issue

Title

Cataract Surgery With Intracameral Triamcinolone in Infants
The Use of Intraocular Triamcinolone in the Perioperative Period of Congenital Cataract Surgery

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    60
The aim of the present study is to investigate the outcomes of congenital cataract surgery when injecting intraoperative intracameral triamcinolone versus the postoperative use of oral prednisolone.

This is a prospective, randomized clinical trial. Sixty children will be submitted to congenital cataract surgery younger than 2 years of age. They will be randomly divided in two groups. The study group will receive an intraoperative intracameral triamcinolone acetonide injection. The control group will receive prednisolone syrup postoperatively. The surgical outcomes will be assessed after one year.
Study Started
Jan 31
2010
Primary Completion
Mar 31
2013
Last Update
Aug 14
2013
Estimate

Drug Triamcinolone acetonide

  • Other names: Triancinolona Ophthalmos

Drug Prednisolone syrup

Triamcinolone acetonide Active Comparator

The study group will receive an intraoperative intracameral injection of triamcinolone acetonide

Prednisolone syrup Active Comparator

The control group will receive prednisolone syrup postoperatively

Criteria 

Inclusion Criteria:

Patients younger than 2 years of age
Unilateral or bilateral congenital cataracts compromising the red reflex

Exclusion Criteria:

Corneal opacity
Glaucoma
Aniridia
Subluxated cataract
Traumatic cataract
Complex microphthalmia
Persistant hyperplastic primary vitreous
Retinal detachment
Patients with intraoperative complications, such as IOL implanted in the sulcus
No Results Posted